Advertisement

Topics

Companies Related to "A Study of RO5045337 in Patients With Solid Tumors" [Most Relevant Company Matches] - Page: 20 RSS

17:33 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "A Study of RO5045337 in Patients With Solid Tumors" found in our extensive corporate database of over 50,000 company records.

Showing "Study RO5045337 Patients With Solid Tumors" Companies 476–500 of 4,700+

Probably Relevant

Body Bar Inc.

Founded in 1987, Body Bar® Inc. provides the infinite workouts and solid educational tools that fitness enthusiasts of all ages and abilities still choose after 23 years - because they work. The company has created a strong presence through the original weighted fitness bar, The Body Bar®, and the extensive "Master Your Body" DVD series of workout programs. We consider passion, integrity and fu...


Lightlake Therapeutics Inc

Lightlake Therapeutics is an early stage biopharmaceutical company aiming to build a solid platform of pharmacological treatments based on our expertise using opioid antagonists. Other significant developments include the use of an opioid antagonist nasal spray to address binge-eating obesity. A Phase II trial of this product in Helsinki is due to be compl...

Lightlake Therapeutics Inc.

Lightlake Therapeutics is an early stage biopharmaceutical company aiming to build a solid platform of pharmacological treatments based on our expertise using opioid antagonists. Other significant developments include the use of an opioid antagonist nasal spray to address binge-eating obesity. A Phase II trial of this product in Helsinki is due to be compl...


Beckstrand Cancer Foundation

Beckstrand Cancer Foundation is a 501(c)(3) organization founded in 1974 by Dr. Grant Beckstrand and a group of doctors specializing in the treatment and care of cancer patients. The Foundation’s goal has been to improve and enhance the quality of life for cancer patients and their families, a mission achieved through unique programs which provide fin...

IRX Therapeutics, Inc.

IRX Therapeutics is a clinical-stage company developing novel immunotherapies focused on reducing the immune suppression that is seen in the cancer tumor micro-environment, restoring immune function, and activating a coordinated immune response against the tumor. The lead candidate, IRX-2, is a proprietary therapeutic containing numerous active cytokine co...

Critical Homecare Solutions

CHS is a leading provider of comprehensive home infusion therapy and specialty infusion services to patients suffering from acute or chronic conditions. CHS delivers infusion pharmaceuticals, biopharmaceuticals, nutrients and related services each year to patients in the home through 35 infusion locations in 22 states, primarily in the eastern United States. CHS also provides nursing and therapy v...

Berkeley Patients Group

BPG opened its doors on October 31,1999 in Berkeley, California with the mission of providing safe and affordable access to quality medicine and life-enhancing services to Bay Area patients suffering from serious illnesses. Their philosophy of putting patients before all else compels the leadership team to be a philanthropic force in the Berkeley community...

Cinfirma Incorporated

Confirma, Inc. is a development stage company focused on developing and marketing non-invasive medical devices which will help doctors make more informed patient management decisions for their cancer patients. Products that will reduce the time and expense associated with achieving an accurate staging and monitoring the progress of therapy.The most important factor used to make cancer therapy deci...

GiveForward.com and MedicalBillMediation.com and The Karis Group

According to a National Bureau of Economic Research study, 50% of Americans cannot come up with $2,000 for a medical emergency. This partnership comes at a time when health care is unaffordable for many Americans, and those families struggling with the everyday cost of living now have a viable solution to substantial medical costs if they occur.

The Body The Complete HIV/AIDS Resource

The Body's mission is to:Use the Web to lower barriers between patients and clinicians. Demystify HIV/AIDS and its treatment. Improve patients' quality of life. Foster community through human connection.

Accredo Nova Factor

For more than 20 years, Accredo Nova Factor has provided nationwide distribution and pharmaceutical care management for the biopharmaceutical industry. Accredo Nova Factor currently has 15 product lines that are dispensed from its specialty pharmacy headquarters in Memphis, Tenn. The products are usually shipped overnight to the patients' homes, where patients are trained to reconstitute and self-...

Bend Research Inc.

For more than 35 years, Bend Research has worked with clients to create value by advancing new medicines that improve human health and to solve their most difficult scientific and technical problems. This success is based on the company's ability to develop, advance, and commercialize pharmaceutical technologies, which grow from a solid base of scientific ...

MedExGen Inc.

MedExGen is a biotechnology company that aims to discover and develop, through comprehensive methods and techniques, new proprietary platform technologies, which will greatly impact and positively improve the lives of everyday people. The eventual end commercialization of our technologies are on the role of our alliances. We continuously develop our internal strengths and capabilities while reachi...

PPD, Inc. and Bend Research, Inc.

For more than 30 years, Bend Research has worked with clients to create value by advancing new medicines and to solve their most difficult scientific and technical problems. This success is based on the company’s ability to develop, advance and commercialize pharmaceutical technologies. The firm’s innovative drug delivery solutions grow from a so...

Accuray Incorporated

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in ...

Vivior

Vivior is a Swiss digital health start-up founded in 2017 by a group of experienced eye care professionals. The company develops a novel wearable device to objectively measure patient’s behavioral data prior to cataract and refractive eye surgeries. The device collects daily activity data from patients, processes these data in the cloud and analyses p...

Vivior AG

Vivior is a Swiss digital health start-up founded in 2017 by a group of experienced eye care professionals. The company develops a novel wearable device to objectively measure patient’s behavioral data prior to cataract and refractive eye surgeries. The device collects daily activity data from patients, processes these data in the cloud and analyses p...

BioTeknica, Inc.

BioTeknica, Inc. (www.BioTeknica.com) is a consulting firm that specializes in the full range of quality systems and engineering services for the medical device, pharmaceutical, and biologic industries. Established in 1996, BioTeknica has a solid track record of providing over 100 companies and their manufacturing sites with resolution to regulatory compliance, software, technology transfer, valid...

Colorcon, Inc.

Colorcon is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical industry. Our best-in-class products and technologies are complemented by our value-added services, which support all phases of solid oral dose design and development.

GenVec

GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines. Each of our gene-based therapeutic product candidates use a common patent-protected technology platform to deliver genes that produce medically beneficial proteins directly at the site of disease. TNFerade™ represents a novel approach to treating cancer in combination with rad...

Long Island Clinical Research Associates

Long Island Clinical Research Associates, LLP (LICRA) is an affiliate organization of Nassau Gastroenterology Associates, P.C. We are a privately owned clinical research center in Great Neck, New York. Conveniently located to New York City and its suburbs, LICRA services a multi-racial and multi-ethnic population of more than 12 million, allowing recruitment from a diverse group of clinical study ...

Vicus Therapeutics, LLC

Vicus Therapeutics is a biopharmaceutical company dedicated to bringing breakthrough therapies to patients with cancer. Vicus' lead investigational therapy, VT-122, is a combination of etodolac and propranolol. VT-122 showed positive results in a Phase 2 clinical trial of lung cancer patients and is currently being evaluated in a Phase 2 clinical trial of liver cancer patients receiving Nexavar ...

Leafly

Leafly serves patients -- a trusted resource where patients can learn about strains and research dispensaries. Leafly has advertising clients in eight states.

Patient Engagement Systems® (PES)

Patient Engagement Systems® (PES) is a nationally recognized healthcare services company dedicated to supporting its customers’ goal of helping people with chronic diseases, specifically diabetes and chronic kidney disease, improve their health, and reduce costs related to inpatient admissions and ER visits. PES provides medical groups, IPAs, health ...

Umeå University

In 2005 we celebrated our 40th birthday. By academic standards, that is considered very young. Maybe our youth is also why the university is alive with enthusiasm, creativity and original ideas. With its 4,000 or so employees and 28,000 students, the university is active across a wide spectrum of fields.We are proud of Umeå University and aim to keep on working towards making it one of Scandinavi...


More From BioPortfolio on "A Study of RO5045337 in Patients With Solid Tumors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks